Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Hypertension|August 7, 2007
Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndromePaul Ernsberger, Janean L Johnson, Talma Rosenthal, et al.
Metabolism: Clinical and Experimental|January 15, 2010
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activationFiras Younis, Naftali Stern, Rona Limor, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 29, 2011
Effect of non-drug interventions on arterial properties determined from 24-h ambulatory blood pressure measurementsBenjamin Gavish, Ariela Alter, Yael Barkai, et al.
Basic & Clinical Pharmacology & Toxicology|March 16, 2013
Effects of antihypertensive and triglyceride lowering agents on splenocyte apoptosis in rats with fatty liverZvi Ackerman, Maria Grozovski, Mor Oron-Herman, et al.
Hypertension (Dallas, Tex. : 1979)|April 13, 2005
Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reductionZvi Ackerman, Mor Oron-Herman, Maria Grozovski, et al.
Atherosclerosis|November 16, 2005
The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndromeMor Oron-Herman, Talma Rosenthal, David Mirelman, et al.
Digestive Diseases and Sciences|August 22, 2007
Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liverZvi Ackerman, Mor Oron-Herman, Talma Rosenthal, et al.
European Journal of Pharmacology|July 16, 2016
Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histologyFiras M Younis, Tamar Blumenthal-Katzir, Kenneth Hollander, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 10, 2018
Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) RatFiras Younis, Jonathan Leor, Zaid Abassi, et al.
American Journal of Hypertension|December 4, 2003
The effects of allicin on weight in fructose-induced hyperinsulinemic, hyperlipidemic, hypertensive ratsAmitai Elkayam, David Mirelman, Edna Peleg, et al.
Pageof 5